01 6Fiasp
02 5NovoMix
03 1NovoMix/NovoLog Mix
04 5NovoRapid
05 1NovoRapid/NovoLog
06 2Novomix/Novolog Mix
07 2Novorapid/Novolog
08 5Ryzodeg
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 210
2019 Revenue in Millions : 162
Growth (%) : 30
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 225
2019 Revenue in Millions : 202
Growth (%) : 11
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 1,567
2019 Revenue in Millions : 1,559
Growth (%) : 1
Main Therapeutic Indication : Diabetes
Currency : USD
2020 Revenue in Millions : 2,753
2019 Revenue in Millions : 2,937
Growth (%) : -6
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 1,447
2020 Revenue in Millions : 1,541
Growth (%) : -1
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 2,429
2020 Revenue in Millions : 2,708
Growth (%) : -6
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 261
2020 Revenue in Millions : 207
Growth (%) : 33
Main Therapeutic Indication : Diabetes
Currency : USD
2021 Revenue in Millions : 266
2020 Revenue in Millions : 222
Growth (%) : 26
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 292
2021 Revenue in Millions : 266
Growth (%) : 10
Main Therapeutic Indication : Diabetes
Currency : USD
2022 Revenue in Millions : 1,119
2021 Revenue in Millions : 1,447
Growth (%) : -23
